TransAct Technologies Incorporated

Last updated September 27, 2026

Organization details

Legal name
TransAct Technologies Incorporated
Ownership
Public
Status
Active
Sector (GICS)
Information Technology
SIC code
3577 — Computer Peripheral Equipment, NEC
Jurisdiction of incorporation
Delaware
Headquarters city
Hamden
Headquarters state / province
Connecticut
Headquarters country
United States
Fiscal year end
December
Ticker symbol
TACT
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001017303
EIN
06-1456680

Board of directors

Chief executives

Dates unknown
John Dillon · CEO
Dates unknown

Board connections

5 of this board's directors also sit on 4 other boards. 1 is in the same sector.

Network of TransAct Technologies Incorporated's board connections MultiSensor AI Holdings Inc. MultiSensor AI Holding... Quest Resource Holding Corporation Quest Resource Holding... The ONE Group Hospitality Inc. The ONE Group Hospital... American Public Education Inc. American Public Educat... Audrey Dunning Audrey Dunning Daniel M. Friedberg Daniel M. Friedberg Emanuel N. Hilario Emanuel N. Hilario Haydee Olinger Haydee Olinger Michael David Braner Michael David Braner TransAct Technologies Inco...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$351,037
2 purchases by 1 insider
Sold, last 12 months
$4,300
1 sale by 1 insider
Date Insider Transaction Shares Price Value
Aug 3, 2026 John Dillon Director, Officer (President and CEO) Option exercise +12,050 — —
Jun 30, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Option exercise +41,747 — —
Jun 30, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Shares withheld for tax −16,422 $5.84 $95,904
Jun 4, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Option exercise +12,500 — —
Jun 4, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Shares withheld for tax −4,291 $4.66 $19,996
May 4, 2026 325 Capital GP, LLC Director, 10% owner Option exercise +1,700 — —
May 4, 2026 Audrey Dunning Director Option exercise +1,700 — —
May 1, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Option exercise +10,100 — —
May 1, 2026 Richtsmeier Brent Officer (Chief Technology Officer) Option exercise +6,325 — —
May 1, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Shares withheld for tax −3,467 $3.32 $11,510
Mar 16, 2026 John Dillon Director, Officer (CEO) Open-market purchase +70,902 $3.49 $247,448
Mar 13, 2026 John Dillon Director, Officer (CEO) Open-market purchase +29,098 $3.56 $103,589
Mar 4, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Option exercise +12,500 — —
Mar 4, 2026 DEMARTINO STEVEN A Officer (President, CFO, Treas. & Secr.) Shares withheld for tax −4,240 $3.48 $14,755
Mar 2, 2026 John Dillon Officer (CEO) Option exercise +1,250 — —

Organizations in the same sector, closest in location and size first.

Questions about TransAct Technologies Incorporated

Who is the CEO of TransAct Technologies Incorporated?

Bart C. Shuldman is TransAct Technologies Incorporated's CEO.

How many directors are on TransAct Technologies Incorporated's board?

TransAct Technologies Incorporated's board has 10 directors: Anil K. Shrivastava, Audrey Dunning, Bart C. Shuldman, Daniel M. Friedberg, Emanuel N. Hilario, Emanuel P.n. Hilario, Haydee Olinger, John Dillon, Michael David Braner and Randall S. Friedman.

Are TransAct Technologies Incorporated insiders buying or selling shares?

Over the last 12 months, TransAct Technologies Incorporated insiders bought $351,037 of shares in 2 purchases and sold $4,300 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="transact-technologies-incorporated"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.